However, either because of some acquired resistant mechanism to anti-aromatase treatments or because of SNPs that can be found in different breast cancer cell lines, anastrozole does not reduce estrogen levels in all TNBC cases. This evidence concerns the gene CYP19A1 and breast carcinoma.